This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Solt, D. B. Articles by Farber, E. Search for Related Content PubMed PubMed Citation Articles by Solt, D. B. Articles by Farber, E.

Comparison of the Blood Supply to Diethylnitrosamine-induced Hyperplastic Nodules and Hepatomas and to the Surrounding Liver¹

Department of Pathology, University of Toronto, Toronto, Ontario, Canada M5S 1A8

Intravascular injection of radionuclide-labeled microspheres was used to compare the blood supply to diethylnitrosamine-induced hyperplastic liver nodules and hepatomas with the blood supply to the surrounding, histologically normal liver. Microspheres injected into the heart or portal vein lodged in the organs of control and diethylnitrosamine-treated rats providing a quantitative index of blood supply to the microvascular bed. The blood supply is expressed as percentage of cardiac output (arterial) or cpm (portal) per organ, lobe, g tissue, etc.

The fraction of the cardiac output received by lung, kidneys, spleen, and liver was similar in control and carcinogen-treated animals. The arterial blood supply of 23 nodules and hepatomas was variable [1.17 ± 0.22% (S.E.) cardiac output per g, fixed weight], but it was similar to the arterial supply to the surrounding tissue (1.12 ± 0.21% cardiac output per g, fixed weight). In contrast the portal blood supply to 25 selected lesions was 39 ± 6% that of the surrounding liver tissue. There was no apparent relationship between blood supply and lesion size or histological appearance.

While only 0.13 ± 0.04% of the microspheres injected via the portal system were recovered in the lungs of control rats, approximately 100 times this number bypassed or escaped the liver containing nodules and hepatomas and lodged in the lungs.

Such alterations in blood flow could contribute to biological diversification of hepatic lesions in successive stages of cancer evolution and could facilitate metastasis from the liver.

¹ Supported by grants from the National Cancer Institute of Canada, The Connaught Fund of the University of Toronto, and The Medical Research Council of Canada (MA-1056).

² Supported by a Training Grant (DE-2268) from the National Institute of Dental Research to Temple University.

³ To whom requests for reprints should be addressed, at Banting Institute, 100 College Street, Toronto, Ontario, Canada M5G 1L5.

Received 11/15/76. Accepted 3/ 1/77.

This article has been cited by other articles:

				Q. Luo, L. Siconolfi-Baez, P. Annamaneni, M. T. Bielawski, P. M. Novikoff, and R. H. Angeletti Altered protein expression at early-stage rat hepatic neoplasia Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1272 - G1282. [Abstract] [Full Text] [PDF]

				D. E. Malarkey, K. Johnson, L. Ryan, G. Boorman, and R. R. Maronpot New Insights into Functional Aspects of Liver Morphology Toxicol Pathol, January 1, 2005; 33(1): 27 - 34. [Abstract] [Full Text] [PDF]

				J. Kankesan, A. Yusuf, E. Laconi, R. Vanama, G. Bradley, J. J. Thiessen, V. Ling, P. M. Rao, S. Rajalakshmi, and D. S. R. Sarma Effect of PSC 833, an inhibitor of P-glycoprotein, on 1,2-dimethylhydrazine-induced liver carcinogenesis in rats Carcinogenesis, December 1, 2003; 24(12): 1977 - 1984. [Abstract] [Full Text] [PDF]